Development of a Curcumin-Loaded Lecithin/Chitosan Nanoparticle Utilizing a Box-Behnken Design of Experiment: Formulation Design and Influence of Process Parameters

Curcumin (CUR) has impressive pharmacologic properties, including cardioprotective, neuroprotective, antimicrobial, and anticancer activity. However, the pharmaceutical application of CUR is limited due to its poor aqueous solubility and low bioavailability. The development of novel formulations has attracted considerable attention to the idea of applying nanobiotechnology to improve the therapeutic efficacy of these challenging compounds. In this study, CUR-loaded lecithin–chitosan nanoparticles (CUR/LCSNPs) were developed and optimized by the concentration of chitosan, lecithin, and stirring speed by a 3-factorial Box-Behnken statistical design, resulting in an optimal concentration of chitosan (A) and lecithin (B) with a 1200 rpm stirring speed (C), with applied constraints of minimal average particle size (Y1), optimal zeta potential (Y2), and maximum entrapment efficiency (%EE) (Y3). The mean particle size of the checkpoint formulation ranged from 136.44 ± 1.74 nm to 267.94 ± 3.72, with a zeta potential of 18.5 ± 1.39 mV to 36.8 ± 3.24 mV and %EE of 69.84 ± 1.51% to 78.50 ± 2.11%. The mean particle size, zeta potential, %EE, and % cumulative drug release from the optimized formulation were 138.43 ± 2.09 nm, +18.98 ± 0.72 mV, 77.39 ± 1.70%, and 86.18 ± 1.5%, respectively. In vitro drug release followed the Korsmeyer–Peppas model with Fickian diffusion (n < 0.45). The optimized technique has proven successful, resulting in a nanoformulation that can be used for the high loading and controlled release of lipophilic drugs.

[1]  H. Alyami,et al.  Preparation and Characterization of Curcumin Nanoemulgel Utilizing Ultrasonication Technique for Wound Healing: In Vitro, Ex Vivo, and In Vivo Evaluation , 2021, Gels.

[2]  D. Panda,et al.  Berberine Encapsulated Lecithin–Chitosan Nanoparticles as Innovative Wound Healing Agent in Type II Diabetes , 2021, Pharmaceutics.

[3]  Yang Wei,et al.  Development of curcumin loaded core-shell zein microparticles stabilized by cellulose nanocrystals and whey protein microgels through interparticle interactions. , 2021, Food & function.

[4]  A. ElMeshad,et al.  Chitosan Nanocarrier Entrapping Hydrophilic Drugs as Advanced Polymeric System for Dual Pharmaceutical and Cosmeceutical Application: A Comprehensive Analysis Using Box-Behnken Design , 2021, Polymers.

[5]  M. H. Warsi,et al.  Progress in nanomedicine-based drug delivery in designing of chitosan nanoparticles for cancer therapy , 2021, International Journal of Polymeric Materials and Polymeric Biomaterials.

[6]  W. Abraham,et al.  Chitosan nanoparticles potentiate the in vitro and in vivo effects of curcumin and other natural compounds. , 2020, Current medicinal chemistry.

[7]  M. H. Warsi,et al.  Formulation design and evaluation of aceclofenac nanogel for topical application. , 2020, Therapeutic delivery.

[8]  A. Amaral,et al.  Melatonin loaded lecithin-chitosan nanoparticles improved the wound healing in diabetic rats. , 2020, International journal of biological macromolecules.

[9]  P. Ravi,et al.  Self-assembled lecithin-chitosan nanoparticle improve the oral bioavailability and alter the pharmacokinetics of raloxifene. , 2020, International journal of pharmaceutics.

[10]  J. Ahmad,et al.  Nanoemulsion loaded polymeric hydrogel for topical delivery of curcumin in psoriasis , 2020 .

[11]  J. Ahmad,et al.  Co-Delivery of Imiquimod and Curcumin by Nanoemugel for Improved Topical Delivery and Reduced Psoriasis-Like Skin Lesions , 2020, Biomolecules.

[12]  K. Hosny,et al.  Preparation and optimization of pravastatin-naringenin nanotransfersomes to enhance bioavailability and reduce hepatic side effects , 2020 .

[13]  Prasada Rao Manchineni,et al.  Statistical Design and Optimization of Sustained Release Formulations of Pravastatin , 2020, Turkish journal of pharmaceutical sciences.

[14]  B. Gupta,et al.  Novel thymoquinone loaded chitosan-lecithin micelles for effective wound healing: Development, characterization, and preclinical evaluation. , 2020, Carbohydrate polymers.

[15]  A. A. Öztürk,et al.  Levocetirizine Dihydrochloride-Loaded Chitosan Nanoparticles: Formulation and In Vitro Evaluation , 2018, Turkish journal of pharmaceutical sciences.

[16]  Xing Tang,et al.  Pharmaceutical strategies of improving oral systemic bioavailability of curcumin for clinical application. , 2019, Journal of controlled release : official journal of the Controlled Release Society.

[17]  Musaed Alkholief Optimization of Lecithin-Chitosan nanoparticles for simultaneous encapsulation of doxorubicin and piperine , 2019, Journal of Drug Delivery Science and Technology.

[18]  P. Devarajan,et al.  Enhancing Curcumin Oral Bioavailability Through Nanoformulations , 2019, European Journal of Drug Metabolism and Pharmacokinetics.

[19]  K. Viravaidya-Pasuwat,et al.  Development of anti-HER2-targeted doxorubicin–core-shell chitosan nanoparticles for the treatment of human breast cancer , 2019, International journal of nanomedicine.

[20]  G. Vayssilov,et al.  Optimization and in-vitro/in-vivo evaluation of doxorubicin-loaded chitosan-alginate nanoparticles using a melanoma mouse model. , 2019, International journal of pharmaceutics.

[21]  Zahra Sayyar,et al.  Photocatalytic and antibacterial activities study of prepared self-cleaning nanostructure surfaces using synthesized and coated ZnO nanoparticles with Curcumin nanodispersion , 2018, Zeitschrift für Kristallographie - Crystalline Materials.

[22]  A. Ganem,et al.  Lecithin–chitosan–TPGS nanoparticles as nanocarriers of (−)-epicatechin enhanced its anticancer activity in breast cancer cells , 2018, RSC advances.

[23]  A. A. Öztürk,et al.  Levocetirizine Dihydrochloride Loaded Chitosan Nanoparticles: Formulation and In Vitro Evaluation , 2018, Turkish Journal of Pharmaceutical Sciences.

[24]  E. Wasan,et al.  An Overview of Chitosan Nanoparticles and Its Application in Non-Parenteral Drug Delivery , 2017, Pharmaceutics.

[25]  Robert J. Lee,et al.  Liposomal curcumin and its application in cancer , 2017, International journal of nanomedicine.

[26]  Kaiyan Lou,et al.  Preparation and characterization of β-cyclodextrin grafted N-maleoyl chitosan nanoparticles for drug delivery , 2017, Asian journal of pharmaceutical sciences.

[27]  N. Sağlam,et al.  Kaempferol loaded lecithin/chitosan nanoparticles: preparation, characterization, and their potential applications as a sustainable antifungal agent , 2017, Artificial cells, nanomedicine, and biotechnology.

[28]  N. A. Megrab,et al.  Optimization of methotrexate loaded niosomes by Box–Behnken design: an understanding of solvent effect and formulation variability , 2017, Drug development and industrial pharmacy.

[29]  L. Bedoya,et al.  Influence of Chitosan Swelling Behaviour on Controlled Release of Tenofovir from Mucoadhesive Vaginal Systems for Prevention of Sexual Transmission of HIV , 2017, Marine drugs.

[30]  A. Alshamsan,et al.  Optimizing indomethacin-loaded chitosan nanoparticle size, encapsulation, and release using Box-Behnken experimental design. , 2016, International journal of biological macromolecules.

[31]  Mohammad Shabib Akhtar,et al.  Progress in nanotechnology-based drug carrier in designing of curcumin nanomedicines for cancer therapy: current state-of-the-art , 2016, Journal of drug targeting.

[32]  K. M. Chacko,et al.  Systematic and comprehensive investigation of the toxicity of curcuminoid-essential oil complex: A bioavailable turmeric formulation , 2015, Molecular medicine reports.

[33]  F. Ahmad,et al.  Transformation of curcumin from food additive to multifunctional medicine: nanotechnology bridging the gap. , 2014, Current drug discovery technologies.

[34]  R. Mason,et al.  Recent advances in curcumin nanoformulation for cancer therapy , 2014, Expert opinion on drug delivery.

[35]  Waseem Kaialy,et al.  Aqueous and hydro-alcoholic media effects on polyols. , 2013, Colloids and surfaces. B, Biointerfaces.

[36]  J. Siepmann,et al.  Mathematical modeling of drug dissolution. , 2013, International journal of pharmaceutics.

[37]  A. Alshamsan,et al.  Part I: Development and optimization of solid-lipid nanoparticles using Box-Behnken statistical design for ocular delivery of gatifloxacin. , 2013, Journal of biomedical materials research. Part A.

[38]  C. Mohanty,et al.  Emerging role of nanocarriers to increase the solubility and bioavailability of curcumin , 2012, Expert opinion on drug delivery.

[39]  P. Couvreur,et al.  Preparation and characterization of biocompatible chitosan nanoparticles for targeted brain delivery of peptides. , 2012, Methods in molecular biology.

[40]  A. Zidan,et al.  Multivariate optimization of formulation variables influencing flurbiprofen proniosomes characteristics. , 2011, Journal of pharmaceutical sciences.

[41]  Wei Chen,et al.  Synthesis and in vitro/in vivo anti-cancer evaluation of curcumin-loaded chitosan/poly(butyl cyanoacrylate) nanoparticles. , 2010, International journal of pharmaceutics.

[42]  Robert A Newman,et al.  Bioavailability of curcumin: problems and promises. , 2007, Molecular pharmaceutics.

[43]  P. Colombo,et al.  Formation of self-organized nanoparticles by lecithin/chitosan ionic interaction. , 2006, International journal of pharmaceutics.

[44]  Ricky A. Sharma,et al.  Curcumin: the story so far. , 2005, European journal of cancer.

[45]  D. Dickson The story so far… , 2000, Nature.